Latest Regulatory Reform News

Challenger has reported a robust FY25 performance, with normalised net profit after tax rising 9% to $456 million and return on equity exceeding targets. The company’s strategic focus on annuities and digital transformation positions it well for continued growth in FY26.

Challenger Limited reported a 9% increase in normalised net profit after tax for FY25, driven by strong Life business cash earnings and resilient Funds Management performance despite net outflows. The company also announced an 11% dividend increase and provided positive FY26 EPS guidance amid ongoing regulatory reforms.

Challenger Limited reported a robust FY25 with a 9% rise in normalised profit and a strategic push into digital transformation and retirement income solutions.

Suncorp Group reports a robust $1.82 billion net profit after tax for FY25, boosted by strategic divestments and strong insurance operations. The company announces a $400 million share buy-back as it sharpens focus on general insurance.

Seven West Media reports a robust 33% rise in underlying net profit, driven by a 26% jump in 7plus digital revenue, even as traditional TV advertising revenue declines by 4%.

AMP Limited reported a 9.2% rise in underlying NPAT to $131 million for the first half of 2025, driven by growth in wealth management cashflows and cost efficiencies. The company declared a 2.0 cents per share interim dividend and reaffirmed its full-year guidance amid ongoing digital banking expansion and AI integration.

Critical Resources Limited has executed binding agreements to acquire a strategic gold-antimony portfolio in New Zealand’s Otago and Reefton regions, including the drill-ready Cap Burn project near OceanaGold’s Macraes mine. This low-cost entry into a Tier-1 jurisdiction offers promising exploration upside supported by recent geological analogues and regulatory reforms.

Flagship Minerals has strategically repositioned towards gold and copper, highlighted by its acquisition of the Pantanillo Gold Project in Chile, aiming for a rapid development path and resource growth. The company plans to commence drilling in October 2025 while rationalising its lithium exposure.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Greenwing Resources reports solid progress across its lithium and graphite assets in Argentina, Madagascar, and Tasmania, completing a $3.5 million equity raise and appointing a new chairman.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.

Wrkr Ltd reports sustained positive operating cash flow and strategic investments positioning it for growth despite an anticipated FY25 EBITDA loss. The company’s landmark deals and platform enhancements signal readiness for upcoming regulatory reforms.